After the safety and efficacy of a biopharmaceutical, the efficiency of bioprocessing it might be the most crucial aspect. As Aleksandr Pogodaev, PhD—principal scientist in pharmacometrics, Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback